Search
forResearch 10 of 1000+
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
- FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair loss
- Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
- Hair growth–promoting effects of Enz_MoriL on human dermal papilla cells through modulation of the Wnt/β-Catenin and JAK-STAT signaling pathways
- A clinical case of familial alopecia areata in combination with immune pathology
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Innovative Therapeutic Strategies in TYK2-Targeted Treatments: From Cancer to Autoimmune Disorders
- Identification of potential key genes and pathways associated with the Pashmina fiber initiation using RNA-Seq and integrated bioinformatics analysis
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →